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Abstract Very few sports use only endurance or strength.
Outside of running long distances on a flat surface and
power-lifting, practically all sports require some combi-
nation of endurance and strength. Endurance and strength
can be developed simultaneously to some degree. How-
ever, the development of a high level of endurance seems
to prohibit the development or maintenance of muscle mass
and strength. This interaction between endurance and
strength is called the concurrent training effect. This
review specifically defines the concurrent training effect,
discusses the potential molecular mechanisms underlying
this effect, and proposes strategies to maximize strength
and endurance in the high-level athlete.
1 Introduction
Robert Hickson was a power-lifter when he went to do his
post-doctoral work in the laboratory of Professor John
Holloszy. Every day, Holloszy, the father of endurance
exercise research, would leave the Washington University
Medical Campus and go for runs through the adjoining
Forest Park. In his effort to make a good impression with
his new boss, Dr. Hickson decided to accompany Prof.
Holloszy on his afternoon runs, but soon found that his
muscle mass and strength were decreasing in spite of the
fact that he was still doing his strength training at the same
frequency and intensity. When Hickson approached
Holloszy with his problem, he was told: ‘‘this should be the
first study you do when you have your own lab.’’ True to
his word, the first study that Hickson completed in his new
laboratory at the University of Illinois in Chicago was the
seminal study on concurrent training.
Published in 1980 [1], Hickson’s classic study trained
three groups of subjects: Group 1 performed strength
training alone; Group 2 performed endurance training
alone; and Group 3 performed strength and endurance
together. The strength training was performed 5 days per
week for 10 weeks, and was designed exclusively to
increase leg strength. True to his power-lifting background,
Hickson had his subjects perform all of the exercises with
as much weight as possible. The endurance training was
performed 6 days per week for the same 10-week period
and consisted of 3 days of cycling and 3 days of running.
The cycling exercise consisted of six 5-min intervals at
maximal aerobic capacity (VO2max), whereas the instruc-
tions on the running days were to ‘‘run as fast as possible’’
for 30 min/day in the first week, 35 min/day for the second
week, and 40 min/day for the remainder of the study. The
concurrent training group performed both the strength and
endurance training protocols in a non-standardized order
with between 15 min and 2 h of rest in between.
At the end of the 10-week training program, VO2max was
determined on the bike and treadmill. The strength alone
group showed a 4 % improvement in VO2max on the bike
with no change when measured on the treadmill. In con-
trast, the endurance and concurrent training groups both
increased VO2max by 17 % on the treadmill and *20 % on
the bike. This indicated that strength training does not
negatively affect endurance adaptations or performance. It
should be noted, however, that the concurrent training
group did not increase their bodyweight over the training
period as a result of their strength training. If they had, it
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would be expected that their endurance performance could
be affected, especially during running where they would
have to support and propel this extra mass.
As for strength, average strength in the concurrent and
strength training groups increased at the same rate
throughout the first 6–7 weeks of training (Fig. 1). Strength
continued to increase throughout the entire 10-week
training period in the strength training only group. In
contrast, strength leveled off between the 7th and 8th
weeks in the concurrent training group and surprisingly
decreased during the 9th and 10th weeks of training. This
indicates either that the concurrent training group was
over-reaching or that high-intensity endurance exercise of a
sufficient frequency can inhibit long-term strength
adaptations.
When others have repeated the frequency and intensity
that Hickson employed in his study, they have found a
similar attenuation in strength and, importantly, impaired
muscle fiber hypertrophy [2, 3]. For example, Kraemer and
colleagues [2] showed that running and strength training at
a high intensity for 4 days a week resulted in lower power
concomitant with impaired muscle fiber hypertrophy than
training for strength alone. Strength training alone resulted
in *28 % hypertrophy, whereas concurrent training
resulted in only a *16 % hypertrophy. This indicates that
concurrent endurance training impairs not only strength but
muscle hypertrophy as well.
It is important to note, though, that when the frequency,
intensity, or duration of training is decreased, the degree of
interference decreases. For example, in two separate stud-
ies McCarthy and colleagues showed that cycling 3 days a
week for 50 min at 70 % VO2max was not enough to impair
strength [4] or hypertrophy [5] as a result of concurrent
strength training. Further, Sillanpa¨a¨ et al. showed that
cycling for 30 min twice a week below anaerobic threshold
was not enough to impair strength or lean mass in middle-
aged women [6] or old men [7]. Taken together, these data
suggest that strength and endurance increase concomitantly
up to a point. However, once the frequency increases past
4 days a week or the intensity of endurance exercise
increases above 80 % VO2max, endurance exercise prevents
the increase in muscle mass and strength that occurs with
strength training. This was illustrated nicely in a recent
meta-analysis that demonstrated that the effect size of
strength training alone on muscle hypertrophy was 1.22
and for strength was 1.71 [3]. The corresponding numbers
for concurrent training were 0.8 and 1.28, indicating that,
in a large cohort, endurance exercise impairs muscle size
and strength adaptations [3].
2 Molecular Underpinning of Muscle Hypertrophy
Increased strength is the combined effect of improvements
in neural activation, muscle fiber size, and connective tis-
sue stiffness. Therefore, concomitant endurance exercise
could decrease adaptations of any/all of these physiological
parameters. There does not appear to be a decrease in the
neural (learning) adaptation since in the early stages of
training, when the neural adaptation is the strongest (4, 6,
and 8 weeks), strength is similar between strength and
concurrent training groups [1, 2]. However, it is possible
that neuromuscular fatigue plays a role in the decrease in
force as training continues. At this point, no one has
measured the effect of concurrent training on connective
tissue stiffness, so we are unsure of the role of this tissue in
the impaired strength response. In contrast, as stated above,
there is some evidence that muscle hypertrophy is impaired
in individuals training for both strength and endurance
together compared with those training exclusively with
strength exercises, and that this correlates quite well with
the impaired strength response [2, 3]. Therefore, the pri-
mary effect of endurance exercise seems to be a decrease in
resistance exercise-induced muscle hypertrophy.
Over the last 15 years we have begun to understand the
molecular events that lead to muscle hypertrophy and
increased endurance capacity. These studies have shown
that for exercise-induced muscle hypertrophy, the key
Fig. 1 The concurrent training effect on strength. The figure shows
the increase in one repetition maximum in the squat in subjects who
participated in 10 weeks of high-intensity resistance exercise alone
(resistance), endurance exercise alone (endurance), and both types of
training (concurrent). Also, note that the strength and concurrent
groups both increased their strength together up to 7 weeks, when the
strength group started making greater gains than the concurrent group
(adapted from Hickson [1], with permission). 1RM one repetition
maximum
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signaling molecule is the mechanistic or mammalian target
of rapamycin (mTOR). mTOR is a serine/threonine protein
kinase that exists in two complexes. Both complexes
contain the DEP domain-containing mTOR-interacting
protein (DEPTOR) and the G-protein beta subunit-like
protein (GbL; also known as lsT8). These proteins are
negative and positive regulators of mTOR, respectively.
Complex 1 (mTORC1) also contains the proline-rich Akt
substrate of 40 kDa (PRAS40), an inhibitor of mTORC1
activity and the regulatory-associated protein of mTOR
(raptor), which specifies the substrates that are phosphor-
ylated by mTORC1. Raptor identifies the substrates for
complex 1 by binding to TOS (TOR signaling) motifs, a
five amino-acid sequence, found in proteins such as
eukaryotic initiation factor (eIF) 4E binding protein-1 (4E-
BP1), the 70-kDa ribosomal protein S6 kinase (S6K1),
hypoxia-inducible factor-1 (HIF-1), and PRAS40. In con-
trast, complex 2 (mTORC2) contains the mammalian
stress-activated map kinase-interacting protein 1 (mSIN1),
which is important for targeting to membranes, the scaf-
fold protein observed with rictor (PROTOR), and the
rapamycin-insensitive companion of mTOR (rictor).
Much like raptor in complex 1, rictor identifies the sub-
strates that are phosphorylated by mTOR. However, rictor
does not recognize TOS motifs and, as a result, in com-
plex 2 mTOR is directed towards a completely different
group of proteins including akt/PKB (protein kinase B),
serum- and glucocorticoid-induced protein kinase (SGK),
and protein kinase C (PKC). Importantly, the macrolide
immunosuppressive antibiotic rapamycin specifically
inhibits complex 1, allowing researchers to distinguish
between the two complexes.
Following resistance exercise there is a significant and
sustained increase in the activity of mTORC1, as deter-
mined by an increase in S6K phosphorylation [8] and
activity [9]. The first indication that this increase in mTOR
activity was important for resistance exercise-induced
muscle hypertrophy came from work where we showed
that the activity of mTOR 6 h following resistance exercise
correlated with the increase in muscle mass following
6 weeks of training [8]. This finding in rats has since been
demonstrated in humans [10], suggesting that activation of
mTORC1 is key to increasing muscle mass and strength.
In many cells, mTOR is activated by growth factors as a
way to stimulate protein synthesis [11]. However, resis-
tance exercise activates mTOR in a growth factor-inde-
pendent manner [12]. Unlike growth factors that use a
receptor tyrosine kinase to signal through phosphoinositide
3-kinase (PI3K) to PKB, resistance exercise activates
mTOR without activating PI3K [13]. Instead, resistance
exercise activates an unidentified kinase (Fig. 2) that
phosphorylates the potent mTOR inhibitor tuberin (TSC2)
on RxRxx motifs [14]. When TSC2 is phosphorylated in
this manner, it binds to 14-3-3 proteins and is moved away
from mTOR and its activator Ras-homolog enriched in
brain (Rheb). In this way, Rheb becomes activated and
stimulates mTORC1 activity, leading to increased protein
synthesis.
Contraction-induced dissociation of TSC2 from the
lysosome is not the only thing that occurs following
resistance exercise that leads to the prolonged activation of
mTOR. In the hours after resistance exercise there is also
an increase in the rate of amino acid uptake from the blood
into the muscle. Specifically, leucine and glutamine are
increased within the working muscle [9, 15]. This increase
in leucine within the muscle is likely the result of an
increase in the primary leucine transporter (LAT1) mes-
senger RNA (mRNA) [16] and protein [17]. Interestingly,
the increase in glutamine can help drive leucine uptake
since LAT1 transports glutamine out of the muscle as it
transports leucine into the muscle in a process called ter-
tiary active transport [18]. As leucine enters the muscle it
acts to trigger protein synthesis largely through its ability to
activate mTORC1 [19]. As leucine is taken up, it binds to
the leucyl-transfer RNA (tRNA) synthetase (LRS). This
not only conjugates leucine to its tRNAs, but the LRS also
acts as the first step in the amino acid activation of the
mTORC1 [20]. LRS may serve as a GTPase activating
protein (GAP) towards the small G-protein (RagD), which
in turn is a component of a heterodimer of RagA/B and
RagC/D that is important for amino acid sensing. When
RagD is bound to guanosine triphosphate (GTP) it forms an
inactive complex. LRS catalyzes the hydrolysis of this GTP
to guanosine diphosphate (GDP) and RagD then interacts
with the Ragulator [21]. At the Ragulator, the Rag het-
erodimer interacts with GATOR (GAP Activity Towards
Rags), an octomeric complex that controls the activity of
the Rag proteins [22]. In the presence of amino acids, the
Rags are activated and recruit mTORC1 to the lysosome by
binding to raptor [23, 24]. As discussed above, the activator
of mTOR, Rheb, is also located on the lysosome, so the net
effect of leucine is to bring mTOR to its activator.
Together, these data suggest that resistance exercise
activates mTORC1 through the activation of an RxRxx-
directed kinase that phosphorylates and moves the inhibitor
TSC2 away from the lysosome (Fig. 2). At the same time,
by regulating LAT1, enhanced amino acid uptake moves
mTOR to the lysosome where it can be activated by GTP-
bound Rheb. This complex molecular process explains
both the load-dependent activation of mTOR (more acti-
vation of the RxRxx kinase [14]) and the effects of amino
acid consumption (increased movement of mTOR to the
lysosome and its activator Rheb [23, 24]) on protein syn-
thesis and, finally, muscle hypertrophy [25, 26].
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Even though a molecular mechanism exists for the
activation of mTORC1 by resistance exercise and pro-
tein feeding, this does not prove that mTORC1 is what is
necessary for muscle growth. Evidence that mTORC1
drives load-induced muscle hypertrophy was derived
from experiments using rapamycin to specifically inhibit
the kinase. In mice, Bodine and colleagues showed that
daily injections of rapamycin could inhibit muscle
hypertrophy [27], and in humans, Drummond and col-
leagues showed that rapamycin could block the acute
increase in protein synthesis after resistance exercise
[28]. These experiments suggested that a rapamycin-
sensitive process was required for load-induced muscle
growth. The specific role of mTOR was demonstrated by
an elegant study from the Hornberger laboratory using
mice with a knock-in mutation that made mTOR resis-
tant to treatment with rapamycin [29]. As would be
expected, in the wild-type animals rapamycin completely
blocked muscle hypertrophy. However, in the mice
expressing a rapamycin-resistant mutant of mTOR
muscle, hypertrophy occurred normally both in the pre-
sence and absence of rapamycin [29]. These data showed
conclusively that resistance exercise-induced muscle
hypertrophy is completely dependent on mTOR. There-
fore, research looking for a molecular mechanism
underlying the concurrent training effect has been
focused exclusively on ways that endurance exercise
could inhibit mTORC1 activity.
3 Molecular Underpinning of Enhanced Endurance
Whereas the muscle hypertrophy response to resistance
exercise appears to converge on a single protein complex
(mTOR), endurance adaptations are the result a variety of
metabolic signals and molecules. During endurance exer-
cise the concentration of calcium, oxygen free radicals,
adenosine monophosphate (AMP), lactate, nicotinamide
Fig. 2 The activation of the mechanistic target of rapamycin
complex 1 (mTORC1, mTOR, and raptor complex) following resis-
tance exercise and feeding. Lifting a heavy weight to failure
stimulates a mechanoreceptor that in turn activates an RxRxxS*/T*
kinase (depicted by ??? at the membrane) that phosphorylates and
moves the TSC2 away from the lysosome allowing Rheb to remain in
the GTP bound state. Simultaneously, amino acid uptake and
intracellular amino acid levels increase. The extra amino acids
stimulate the LRS to act as a GAP towards RagC/D and GATOR2
blocks GATOR1 (the GAP of RagA/B) and the Ragulator GTP loads
RagA/B and activates the complex. The active Rag complex then
binds to raptor and positions mTOR beside its activator: GTP bound
Rheb. The resulting elevation of mTORC1 activity drives myofibrillar
protein synthesis and eventually leads to an increase in muscle mass
and strength. DEPTOR DEP (Dishevelled, Egl-10 and Pleckstrin)
domain-containing mTOR-interacting protein, GbL G-protein beta
subunit-like protein, GAP GTPase activating protein, GATOR
GAP Activity Towards Rags, GDP guanosine diphosphate, GTP
guanosine triphosphate, LAMP2 lysosome-associated membrane
protein 2, LAT1 L-type amino acid transporter, LRS leucyl transfer
RNA synthase, mTOR mammalian target of rapamycin, mTORC1
mTOR complex 1 P phosphorylation, PRAS40 proline-rich Akt
substrate of 40 kDa, Rab7 Ras-related protein 7, raptor the regula-
tory-associated protein of mTOR, Rheb Ras homolog enriched in
brain, TSC2 tublerosclerosis complex
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adenine dinucleotide (NAD?), inorganic phosphate, and
glycogen change dramatically within the working muscle.
At the same time, systemic changes in hormones, such as
catecholamines, may influence the muscle and drive
adaptations. These metabolic and hormonal signals turn on
signaling proteins within muscle that, if repeated at a suf-
ficient frequency, lead to enhanced mitochondrial mass,
improved fat and glucose oxidation, and increased capillary
density. For example, calcium released during contraction
activates the calcium-calmodulin kinase (CaMK) family of
proteins, specifically CaMKII in skeletal muscle [30].
Active CaMK can increase both the capacity for glucose
uptake through upregulation of the glucose transporter
GLUT4 [31], and mitochondrial mass by transcriptional
upregulation of the mitochondrial biogenesis regulator
PGC-1a (peroxisome proliferator c coactivator 1a) [32].
The decrease in adenosine triphosphate (ATP) and glyco-
gen and the rise in adenosine diphosphate (ADP) and AMP
during high-intensity endurance exercise activates the
AMP-activated protein kinase (AMPK). Active AMPK is
involved in the increase in fat oxidation during exercise
[33] and also plays a role in the long-term regulation of
mitochondrial mass by controlling the transcription and
activity of PGC-1a [34]. The decrease in glycogen also
activates the 38 kDa mitogen-activated protein kinase
(p38), which, like AMPK, can increase the transcription
and activity of PGC-1a [35–37]. The rise in lactate and
NAD? activates the NAD?-dependent deacetylase family
of sirtuins (SIRT). Members of this family control meta-
bolic flux through the tricarboxylic acid (TCA) cycle,
insulin sensitivity [38], and PGC-1a activity [39]. Last, the
rise in circulating catecholamines through the b-adrenergic
receptor activates the cyclic AMP response element bind-
ing protein (CREB), a transcription factor that is required
for the transcriptional upregulation of PGC-1a [40].
Since all of these signaling molecules are activated by
endurance exercise, it is possible that one or more of them
can simultaneously inhibit mTOR activation and limit
skeletal muscle hypertrophy during concurrent training.
Beyond these signals, which are known to play a positive
role in the adaptation to endurance exercise, the stress of
exercise is known to increase other processes, such as free
radical generation or endoplasmic reticulum (ER) stress
[41, 42] that might influence mTOR activity or protein
synthesis in response to resistance exercise.
4 Current Data on the Molecular Underpinning
of the Concurrent Training Effect
The first hint of a molecular mechanism that could explain
how endurance exercise could impair muscle hypertrophy
of concurrent strength training came when Inoki and
colleagues showed that metabolic stress blocks mTORC1
activity [43]. Of keen interest for exercise physiologists
was the fact that AMPK was required for the inhibitory
effect of metabolic stress on mTOR [43]. The effect of
metabolic stress on mTOR was first suggested to be the
result of AMPK phosphorylating and activating the mTOR
inhibitor TSC2 [43]. Later, another group showed that
AMPK could phosphorylate raptor and dissociate the
mTORC1 [44]. More recently, a third group has shown that
in some cells, metabolic stress inhibits mTOR in an
AMPK-independent manner by preventing mTOR locali-
zation to the lysosome [45].
Regardless of the mechanism, putting together the effect
of metabolic stress/AMPK activation on mTOR and the
fact that metabolic stress and AMPK activity were
increased during endurance exercise, exercise physiologists
began to ask the question ‘‘can AMPK limit muscle
hypertrophy?’’ Thomson and Gordon were the first to show
that impaired muscle growth was seen in rats where AMPK
activity was higher, supporting the hypothesis that AMPK
mediated the concurrent training effect [46]. They went
further using the AMP mimetic AICAR (5-aminoimida-
zole-4-carboxamide ribonucleotide) to activate AMPK in
muscles before resistance exercise and, consistent with the
hypothesis, AICAR treatment blocked S6K phosphoryla-
tion [47]. We then used an animal model of concurrent
training to show that the isoform of AMPK that was acti-
vated by concurrent training (a1) was not the form that was
associated with endurance adaptations (a2), suggesting that
during concurrent training a different form of AMPK was
activated to prevent growth [48]. Consistent with the
hypothesis that a1-AMPK limited growth, mice in which
the a1 isoform of AMPK was knocked out showed a 33 %
greater increase in muscle fiber size and enhanced mTOR
signaling to S6K and 4E-BP1 in response to training than
wild-type mice [49]. It is important to note that the a1-
AMPK knockout mice showed significantly greater a2-
AMPK activity in an effort to compensate for the loss of
a1, but this was unable to restrict growth. Therefore, the
metabolically activated a2 form of AMPK was not as
effective at inhibiting mTOR as the a1 form.
Even though the animal studies have been impressive at
showing that AMPK can directly inhibit mTORC1 activity
and muscle growth, acute studies in humans are not as
definitive. The most interesting of these studies is a pair
from John Hawley’s laboratory [50, 51]. In the first, they
showed that the activation of the mTORC1 following eight
sets of five repetitions at 80 % of their one repetition
maximum (1RM) was completely lost if the subjects had
performed ten 6-second maximal sprint efforts on a bicycle
15 min before strength training, and mTOR activity rapidly
returned to baseline if the sprint session was performed
after strength training [50]. Interestingly, if, instead of
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using a high-intensity sprint session, the authors used a
moderate intensity bout of cycling, there was no difference
in mTORC1 activity [51]. Consistent with endurance
exercise intensity being a key to the interference effect,
Lundberg et al. did not find any inhibition of mTOR acti-
vation when subjects performed 45 min of cycling at 70 %
VO2max 6 h before performing resistance exercise [52].
Further, Apro´ and colleagues did not report any decrease in
mTOR signaling when subjects performed 30 min of
cycling at 70 % of VO2max 15 min after completing a
resistance training session [53]. These findings are com-
pletely consistent with the training data that show that the
interference effect is only seen if the subjects train at a high
frequency and intensity [1, 2], and the fact that the muscle
AMP/ATP ratio and AMPK activity increases with exer-
cise intensity [54]. Even though the intensity effects and
the animal data are completely consistent with AMPK
mediating the inhibition of mTOR activity during concur-
rent training, the activation of AMPK in both of the
training groups was the same in the sprint interval study by
Coffey and colleagues, suggesting that AMPK could not
explain the inhibition of mTOR activity [50]. With the
caveat that the phosphorylation of AMPK is not the most
sensitive measure of AMPK activity (a direct measure of
activity or the phosphorylation of its downstream target
acetyl-CoA carboxylase show both the allosteric activation
by AMP or ADP and the effect of phosphorylation [54]),
this suggests that another molecular signal contributes to,
or better explains, the inhibitory effect of endurance
exercise on muscle hypertrophy.
5 Alternative Molecular Underpinning
of the Concurrent Training Effect
If the activation of AMPK does not completely explain the
concurrent training effect, then what other molecular
events are activated by endurance exercise that could block
mTOR and/or inhibit muscle hypertrophy? As discussed in
Sect. 3, endurance exercise activates the sirtuin family of
NAD?-dependent deactetylases including SIRT1 [55].
Like AMPK, SIRT1 is activated by metabolic stress and as
a result of its relationship with lactate/NAD?, is activated
in an intensity-dependent manner [56]. Further, SIRT1 is
able to inhibit mTOR [57]. In HeLa cells, where AMPK
activity is reduced, the knockdown or inhibition of SIRT1
increased mTORC1 activity, whereas the SIRT1 activator
resveratrol decreased mTOR activity [57]. Further, since
SIRT1 and AMPK signaling are closely linked [58], it is
possible that SIRT1 and not AMPK is the direct mediator
of mTOR inactivation that was discussed above following
high-intensity exercise.
Another way that endurance exercise could inhibit
mTORC1 activity is through the unfolded protein, or ER
stress, pathway. Periods of high lipid exposure, glucose
deprivation, or increased synthesis of secretory proteins,
lead to the accumulation of unfolded or misfolded proteins
within the ER lumen [59]. To cope with the increase in
unfolded proteins, cells activate the unfolded protein
response, a series of events that serve to block general
protein synthesis, increase protein-folding capacity, and
restore ER function. Interestingly, the unfolded protein
response is activated in muscle by acute endurance exercise
[42], a high-fat diet [60], or the combination of both stimuli
[41]. Furthermore, both endurance exercise [2] and a high-
fat diet [61] impair muscle hypertrophy and ER stress
decreases mTORC1 activity and protein synthesis in
muscle [60, 62]. Therefore, like AMPK and SIRT1, the ER
stress response could contribute to the concurrent training
effect.
6 Science-Based Recommendations for Training
to Maximize Concurrent Training
Using the molecular information provided in Sects. 2–5,
some simple nutritional and training strategies can be
devised to maximize the adaptations to concurrent training.
The goal of these recommendations is to maximize the
mitochondrial adaptation to endurance exercise and the
muscle mass and strength adaptation to strength training.
To do this, the following could be recommended:
(a) Any high-intensity endurance training sessions should
be performed early in the day. Then, a period of
recovery of at least 3 h should be given, so that
AMPK and SIRT1 activity can return to baseline
levels, before resistance exercise is performed. This
suggestion is based on the fact that AMPK activity
increases rapidly and then returns to baseline levels
within the first 3 h after high-intensity exercise [63],
whereas mTORC1 activity can be maintained for at
least 18 h after resistance exercise [8, 9].
(b) Resistance exercise should be supported by readily
digestible, leucine-rich protein as soon as possible
after training to maximize leucine uptake [64], mTOR
recruitment to the lysosome [29], and protein synthe-
sis [25]. Since, in this scenario, resistance exercise is
performed later in the day, it becomes even more
important to also consume protein immediately prior
to sleep to maximize the synthetic response overnight
[65].
(c) Fully refuel between the morning high-intensity
endurance training session and the afternoon strength
session since AMPK can be activated by low
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glycogen [66], and SIRT1 is activated by caloric
restriction [38]. If it is not possible to refuel
completely because of the training volume and
intensity, it might be best to reserve a portion of the
offseason (and short periods in season) exclusively for
increasing muscle size and strength and then use
higher dietary protein intakes to maintain that muscle
mass as the aerobic load increases through the season
[67].
(d) To improve the endurance response to lower-intensity
endurance training sessions and provide a strong
strength stimulus, consider performing strength train-
ing immediately after low-intensity, non-depleting,
endurance sessions. Performing a strength session
immediately after a low-intensity endurance session
results in a greater stimulus for endurance adaptation
than the low-intensity endurance session alone [68]
and the low-intensity session will not affect signaling
pathways regulating strength gains [51–53].
7 Conclusions
These simple recommendations, based on our current
understanding of the molecular response to exercise,
should allow for the maximal adaptive response to both
endurance and strength exercise. However, it is important
to remember that what makes a good molecular biologist is
the ability to break down complex physiological processes
into simple molecular switches. Naturally, improving
endurance and strength together in an elite athlete is more
than just striking the balance between AMPK/SIRT1 and
mTORC1. This is especially true in situations where per-
formance is based on skill optimization that goes well
beyond these simple molecular pathways. In the end, how
an athlete performs with their improved endurance and
strength is based on far more complex processes that are
unfortunately poorly understood.
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